For individuals with type 1 diabetes, low-glucose alerts improve the time below range for drivers and reduce the inci ...

New research has come out on how people can decrease the amount of microplastics and nanoplastics (MNPs) they drink and eat.

Trevi Therapeutics (TRVI) announced topline results from its Phase 2a RIVER trial of Haduvio for the treatment of patients with RCC. Haduvio ...

Design: Prospective, randomised, controlled, double-blind, crossover study. Setting: Sports Medicine Unit, Umeå University. Patients: 32 patients (36 elbows), age range 27 to 66 years, with a long ...

Eton Pharmaceuticals (ETON) announced positive results from its bioequivalence study of ET-600, a proprietary, patented oral solution of ...